how are people affording glp 1 From pharmacy to pantry: GLP-1 drugs shifting consumer preferences and shopping patterns Poll: Nearly 1 in 4

The above point (2) provides evidence that loss of GLP-1 secretion with immediate pathophysiological consequences (reduced incretin effect as part of impaired postprandial beta cell function) calls for a replacement therapy with incretin-based glucose-lowering medications [3]

Thus, the basic finding that GLP-1 receptor agonists decrease fluid intake could be especially important in clinical settings, especially with respect to geriatric patient populations that are already at risk for dehydration (6)

Type 2 diabetes, often associated with overweight and obesity, results from the bodys resistance to insulin or insufficient insulin production

Numaga-Tomita T, Shimauchi T, Oda S, Tanaka T, Nishiyama K, Nishimura A et al (2019) TRPC6 regulates phenotypic switching of vascular smooth muscle cells through plasma membrane potential-dependent coupling with PTEN